ITEMS IN AFP WITH KEYWORD:

Family Planning and Contraception

May 15, 2021 Issue
Lactic Acid, Citric Acid, and Potassium Bitartrate (Phexxi) Vaginal Gel for Contraception [STEPS]

Given its high cost, mediocre contraceptive protection, and rate of adverse effects, Phexxi may be preferred only by people desiring to avoid hormonal contraception who wish to use on-demand contraception that they control, or for whom other contraceptive options are not suited or desired.


Mar 1, 2021 Issue
Initiating Hormonal Contraception [Article]

An evidence-based, flexible, patient-centered approach to initiating contraception promotes health and enhances patients’ reproductive autonomy. Delaying contraception to wait for the next menses or for an appointment creates unnecessary barriers for patients. Clinicians can facilitate the use of hormonal contraception by providing anticipatory guidance about common side effects, giving comprehensive information about available contraceptive choices, honoring patients’ preferences, and eliminating office-related barriers.


Jun 1, 2020 Issue
Emergency Contraception: Safety and Effectiveness [Cochrane for Clinicians]

Oral mifepristone (Mifeprex), ulipristal (Ella), levonorgestrel-releasing emergency contraception (Plan B One-Step), ethinyl estradiol/levonorgestrel, and the copper intrauterine device (IUD; Paragard) are safe and effective for emergency contraception.


May 15, 2020 Issue
Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception [STEPS]

Annovera is an effective combined progestin/estrogen contraceptive device that can be used for one year.


May 1, 2019 Issue
Aromatase Inhibitors Such as Letrozole (Femara) vs. Clomiphene (Clomid) for Subfertile Women with PCOS [Cochrane for Clinicians]

When treated with letrozole, subfertile women with PCOS who are trying to conceive have increased chances of pregnancy (number needed to treat [NNT] = 11) and live birth (NNT = 10) compared with those treated with clomiphene.


Sep 1, 2018 Issue
Long-Acting Reversible Contraception: Difficult Insertions and Removals [Article]

Although most long-acting reversible contraception insertions and removals are straightforward, with the rise in the use of intrauterine devices and implants, clinicians are more likely to encounter challenges with these procedures. Learn strategies for managing difficult cases.


Aug 1, 2018 Issue
Treatment Duration for Etonogestrel Implant [FPIN's Help Desk Answers]

The etonogestrel subdermal implant is approved by the U.S. Food and Drug Administration for contraception for up to three years, but it seems to be effective for up to five years.


Jan 1, 2018 Issue
Immediate Postpartum LARC: An Underused Contraceptive Option [Editorials]

Providing immediate postpartum LARC to women who want it is an evidence-based, patient-centered, and safe practice.


Dec 1, 2017 Issue
Local Anesthesia for IUD Insertion or Endometrial Biopsy [FPIN's Help Desk Answers]

Topical application of lidocaine/prilocaine cream to the cervix reduces mean pain scores during IUD insertion. Intrauterine instillation of liquid anesthesia reduces median pain scores during endometrial biopsy.


Jun 1, 2017 Issue
Hormonal Contraceptives in Women Who Are Overweight or Obese [FPIN's Help Desk Answers]

Hormonal contraceptives (oral contraceptive pills, implants, patches, and rings) are highly effective in women of all weights.There is no consistently demonstrated increased risk of pregnancy in overweight women using any specific hormonal method of contraception.


Pages: 1 2 3 4 5 6 7 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now